• レポートコード:QYR9N7750 • 出版社/出版日:QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、92ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医療・製薬・バイオ |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、過活動膀胱治療学のグローバル市場について調査・分析したレポートで、種類別(抗コリン作用薬、ミラベグロン、ボトックス)、用途別(特発性過活動膀胱、神経性過活動膀胱)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。 ・過活動膀胱治療学の世界市場規模 ・主要企業別市場シェア ・過活動膀胱治療学の世界市場規模:種類別(抗コリン作用薬、ミラベグロン、ボトックス) ・過活動膀胱治療学の世界市場規模:用途別(特発性過活動膀胱、神経性過活動膀胱) ・過活動膀胱治療学のアメリカ市場規模(種類別、用途別) ・過活動膀胱治療学のヨーロッパ市場規模(種類別、用途別) ・過活動膀胱治療学の中国市場規模(種類別、用途別) ・過活動膀胱治療学の日本市場規模(種類別、用途別) ・過活動膀胱治療学の東南アジア市場規模(種類別、用途別) ・過活動膀胱治療学のインド市場規模(種類別、用途別) ・過活動膀胱治療学の中南米市場規模(種類別、用途別) ・主要企業別分析(企業概要、製品動向、販売量など) ・過活動膀胱治療学の世界市場予測(2019年-2025年) ・過活動膀胱治療学の地域別市場予測(2019年-2025年) ... |
Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control).North America is the largest consumption market of Overactive Bladder Treatment with prevalence as high as 11% and high medical level. In 2017, North America accounts for 49.59%.
Followed North America, Europe is the second largest consumption market with share of 27.84%. Besides, Japan is also an important market with market share over 17%. China and other Asian countries is the emerging market with the fastest growth rate, though there is no large manufacturer of Overactive Bladder Treatment drugs.
The Overactive Bladder Treatment market can be segmented as Anticholinergics, Mirabegron, Botox and Other Drugs. Among them, Anticholinergics account for the largest market share while it is in a decreasing trend. The growth rate of Mirabegron and Botox is fast.
In 2018, the global Overactive Bladder Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Overactive Bladder Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Overactive Bladder Therapeutics development in United States, Europe and China.
The key players covered in this study
Astellas Pharma
Allergan
Pfizer
Johnson & Johnson
Teva (Activas)
…
Market segment by Type, the product can be split into
Anticholinergics
Mirabegron
Botox
Market segment by Application, split into
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Overactive Bladder Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Overactive Bladder Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Overactive Bladder Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Overactive Bladder Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Anticholinergics
1.4.3 Mirabegron
1.4.4 Botox
1.5 Market by Application
1.5.1 Global Overactive Bladder Therapeutics Market Share by Application (2014-2025)
1.5.2 Idiopathic Overactive Bladder
1.5.3 Neurogenic Overactive Bladder
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Overactive Bladder Therapeutics Market Size
2.2 Overactive Bladder Therapeutics Growth Trends by Regions
2.2.1 Overactive Bladder Therapeutics Market Size by Regions (2014-2025)
2.2.2 Overactive Bladder Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Overactive Bladder Therapeutics Market Size by Manufacturers
3.1.1 Global Overactive Bladder Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Overactive Bladder Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Overactive Bladder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Overactive Bladder Therapeutics Key Players Head office and Area Served
3.3 Key Players Overactive Bladder Therapeutics Product/Solution/Service
3.4 Date of Enter into Overactive Bladder Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Overactive Bladder Therapeutics Market Size by Type (2014-2019)
4.2 Global Overactive Bladder Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Overactive Bladder Therapeutics Market Size (2014-2019)
5.2 Overactive Bladder Therapeutics Key Players in United States
5.3 United States Overactive Bladder Therapeutics Market Size by Type
5.4 United States Overactive Bladder Therapeutics Market Size by Application
6 Europe
6.1 Europe Overactive Bladder Therapeutics Market Size (2014-2019)
6.2 Overactive Bladder Therapeutics Key Players in Europe
6.3 Europe Overactive Bladder Therapeutics Market Size by Type
6.4 Europe Overactive Bladder Therapeutics Market Size by Application
7 China
7.1 China Overactive Bladder Therapeutics Market Size (2014-2019)
7.2 Overactive Bladder Therapeutics Key Players in China
7.3 China Overactive Bladder Therapeutics Market Size by Type
7.4 China Overactive Bladder Therapeutics Market Size by Application
8 Japan
8.1 Japan Overactive Bladder Therapeutics Market Size (2014-2019)
8.2 Overactive Bladder Therapeutics Key Players in Japan
8.3 Japan Overactive Bladder Therapeutics Market Size by Type
8.4 Japan Overactive Bladder Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Overactive Bladder Therapeutics Market Size (2014-2019)
9.2 Overactive Bladder Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Overactive Bladder Therapeutics Market Size by Type
9.4 Southeast Asia Overactive Bladder Therapeutics Market Size by Application
10 India
10.1 India Overactive Bladder Therapeutics Market Size (2014-2019)
10.2 Overactive Bladder Therapeutics Key Players in India
10.3 India Overactive Bladder Therapeutics Market Size by Type
10.4 India Overactive Bladder Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Overactive Bladder Therapeutics Market Size (2014-2019)
11.2 Overactive Bladder Therapeutics Key Players in Central & South America
11.3 Central & South America Overactive Bladder Therapeutics Market Size by Type
11.4 Central & South America Overactive Bladder Therapeutics Market Size by Application
12 International Players Profiles
12.1 Astellas Pharma
12.1.1 Astellas Pharma Company Details
12.1.2 Company Description and Business Overview
12.1.3 Overactive Bladder Therapeutics Introduction
12.1.4 Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2014-2019)
12.1.5 Astellas Pharma Recent Development
12.2 Allergan
12.2.1 Allergan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Overactive Bladder Therapeutics Introduction
12.2.4 Allergan Revenue in Overactive Bladder Therapeutics Business (2014-2019)
12.2.5 Allergan Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Overactive Bladder Therapeutics Introduction
12.3.4 Pfizer Revenue in Overactive Bladder Therapeutics Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Overactive Bladder Therapeutics Introduction
12.4.4 Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Teva (Activas)
12.5.1 Teva (Activas) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Overactive Bladder Therapeutics Introduction
12.5.4 Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2014-2019)
12.5.5 Teva (Activas) Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Overactive Bladder Therapeutics Key Market Segments
Table Key Players Overactive Bladder Therapeutics Covered
Table Global Overactive Bladder Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Overactive Bladder Therapeutics Market Size Market Share by Type 2014-2025
Figure Anticholinergics Figures
Table Key Players of Anticholinergics
Figure Mirabegron Figures
Table Key Players of Mirabegron
Figure Botox Figures
Table Key Players of Botox
Table Global Overactive Bladder Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Idiopathic Overactive Bladder Case Studies
Figure Neurogenic Overactive Bladder Case Studies
Figure Overactive Bladder Therapeutics Report Years Considered
Table Global Overactive Bladder Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Overactive Bladder Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Overactive Bladder Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Overactive Bladder Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Overactive Bladder Therapeutics Market Share by Regions 2014-2019
Figure Global Overactive Bladder Therapeutics Market Share by Regions 2014-2019
Figure Global Overactive Bladder Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Overactive Bladder Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Overactive Bladder Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Overactive Bladder Therapeutics Market Share by Manufacturers in 2018
Table Global Overactive Bladder Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Overactive Bladder Therapeutics Product/Solution/Service
Table Date of Enter into Overactive Bladder Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Overactive Bladder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Overactive Bladder Therapeutics Market Size Share by Type (2014-2019)
Figure Global Overactive Bladder Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Overactive Bladder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Overactive Bladder Therapeutics Market Size Share by Application (2014-2019)
Figure Global Overactive Bladder Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Overactive Bladder Therapeutics Revenue Market Share by Application in 2018
Figure United States Overactive Bladder Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Overactive Bladder Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Overactive Bladder Therapeutics Market Share (2018-2019)
Table United States Overactive Bladder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Overactive Bladder Therapeutics Market Share by Type (2014-2019)
Table United States Overactive Bladder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Overactive Bladder Therapeutics Market Share by Application (2014-2019)
Figure Europe Overactive Bladder Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Overactive Bladder Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Overactive Bladder Therapeutics Market Share (2018-2019)
Table Europe Overactive Bladder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Overactive Bladder Therapeutics Market Share by Type (2014-2019)
Table Europe Overactive Bladder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Overactive Bladder Therapeutics Market Share by Application (2014-2019)
Figure China Overactive Bladder Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Overactive Bladder Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Overactive Bladder Therapeutics Market Share (2018-2019)
Table China Overactive Bladder Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Overactive Bladder Therapeutics Market Share by Type (2014-2019)
Table China Overactive Bladder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Overactive Bladder Therapeutics Market Share by Application (2014-2019)
Figure Japan Overactive Bladder Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Overactive Bladder Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Overactive Bladder Therapeutics Market Share (2018-2019)
Table Japan Overactive Bladder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Overactive Bladder Therapeutics Market Share by Type (2014-2019)
Table Japan Overactive Bladder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Overactive Bladder Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Overactive Bladder Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Overactive Bladder Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Overactive Bladder Therapeutics Market Share (2018-2019)
Table Southeast Asia Overactive Bladder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Overactive Bladder Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Overactive Bladder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Overactive Bladder Therapeutics Market Share by Application (2014-2019)
Figure India Overactive Bladder Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Overactive Bladder Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Overactive Bladder Therapeutics Market Share (2018-2019)
Table India Overactive Bladder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Overactive Bladder Therapeutics Market Share by Type (2014-2019)
Table India Overactive Bladder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Overactive Bladder Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Overactive Bladder Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Overactive Bladder Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Overactive Bladder Therapeutics Market Share (2018-2019)
Table Central & South America Overactive Bladder Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Overactive Bladder Therapeutics Market Share by Type (2014-2019)
Table Central & South America Overactive Bladder Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Overactive Bladder Therapeutics Market Share by Application (2014-2019)
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Overactive Bladder Therapeutics Business (2014-2019) (Million US$)
Figure Astellas Pharma Revenue Growth Rate in Overactive Bladder Therapeutics Business (2014-2019)
Table Astellas Pharma Recent Development
Table Allergan Company Details
Table Allergan Revenue in Overactive Bladder Therapeutics Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Overactive Bladder Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Overactive Bladder Therapeutics Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Overactive Bladder Therapeutics Business (2014-2019)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Overactive Bladder Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Overactive Bladder Therapeutics Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Teva (Activas) Company Details
Table Teva (Activas) Revenue in Overactive Bladder Therapeutics Business (2014-2019)(Million US$)
Figure Teva (Activas) Revenue Growth Rate in Overactive Bladder Therapeutics Business (2014-2019)
Table Teva (Activas) Recent Development
Table Global Overactive Bladder Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Overactive Bladder Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Overactive Bladder Therapeutics Market Size Share by Regions in 2025
Figure United States Overactive Bladder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Overactive Bladder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Overactive Bladder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Overactive Bladder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Overactive Bladder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Overactive Bladder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Overactive Bladder Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Overactive Bladder Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Overactive Bladder Therapeutics Market Size by Product (2019-2025)
Figure Global Overactive Bladder Therapeutics Market Size by Product in 2025
Table Global Overactive Bladder Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Overactive Bladder Therapeutics Market Size by Application (2019-2025)
Figure Global Overactive Bladder Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources